Zebra body myopathy is caused by a mutation in the skeletal muscle actin gene (ACTA1)

C A Sewry1, J L Holton2, D J Dick3

  • 1Dubowitz Neuromuscular Centre, UCL Institute of Child Health and Great Ormond Street Hospital for Children, London, UK; Wolfson Centre for Inherited Neuromuscular Diseases, RJAH Orthopaedic Hospital, Oswestry, UK.

Insights

This study identifies a new mutation in the ACTA1 gene in a patient with zebra body myopathy, confirming it as part of the ACTA1-related myopathy spectrum. The findings show that actin accumulation can occur in non-neonatal cases, with potential disease progression.

Area of Science:

  • Neurology
  • Genetics
  • Pathology

Background:

  • Follow-up study of the original 'zebra body myopathy' case from 1975.
  • Investigates pathological features in a second biopsy at age 29.

Observation:

  • Second biopsy revealed significant fiber size variation, split fibers, internal nuclei, and endomysial fibrosis.
  • Observed rimmed vacuoles, myofibrillar material accumulation, and enzyme-deficient areas.
  • Presence of nemaline rods, actin-like filaments, and small zebra bodies noted.

Findings:

  • Identified a novel de novo ACTA1 gene mutation (c.1043T>p.Leu348Gln).
  • Confirmed ACTA1 as the causative gene for this form of zebra body myopathy.
  • Demonstrated that actin filament accumulation is not limited to severe neonatal ACTA1 myopathies.

Implications:

  • Zebra body myopathy is now recognized as part of the ACTA1 gene-related myopathy spectrum.
  • Highlights the potential for progressive weakness in congenital myopathies.
  • Suggests ACTA1 mutations should be considered in congenital myopathies with progressive weakness and specific pathological findings.